Inspire Investing, LLC Catalent, Inc. Transaction History

Inspire Investing, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$31.86 - $67.26 $59,578 - $125,776	1,870 Added 6.9%	28,969 $1.26 Million
Q1 2023 Apr 24, 2023	BUY	$45.44 - $74.26 $65,978 - $107,825	1,452 Added 5.66%	27,099 $1.78 Million
Q4 2022 Jan 26, 2023	BUY	$41.39 - $81.0 $114,857 - $224,775	2,775 Added 12.13%	25,647 $0
Q3 2022 Nov 07, 2022	BUY	$72.36 - $113.1 $78,727 - $123,052	1,088 Added 4.99%	22,872 $1.66 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $118,504 - $154,993	-1,359 Reduced 5.87%	21,784 $2.34 Million
Q1 2022 Apr 21, 2022	SELL	$94.19 - $124.49 $74,692 - $98,720	-793 Reduced 3.31%	23,143 $2.57 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $2.86 Million - $3.33 Million	23,936 New	23,936 $3.07 Million
Q4 2021 Feb 03, 2022	SELL	$119.57 - $139.07 $2.51 Million - $2.92 Million	-20,999 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$109.17 - $142.35 $2.29 Million - $2.99 Million	20,999 New	20,999 $2.79 Million
Q1 2018 Apr 13, 2018	SELL	$39.4 - $47.39 $54,017 - $64,971	-1,371 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$37.27 - $43.02 $51,097 - $58,980	1,371	1,371 $56,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.